AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-91394002/meda-ab-signs-european.html" title="Facts and information about Meda AB signs European licensing deal with Vivus Inc.(contract details)(Brief Article)">Meda AB signs European licensing deal with Vivus Inc.(contract details)(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from M2 Europharma are available.
Frequently asked questions about RSS feeds
Meda AB signs European licensing deal with Vivus Inc.(contract details)(Brief Article)
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
Swedish pharmaceutical company Meda AB has signed a long-term licensing agreement with the US company Vivus Inc.
Under the agreement signed by the parties Meda would have exclusive rights to market Vivus' erectile dysfunction drug MUSE in Europe, Meda said.
The European …
Related articles from newspapers, magazines, journals, and more
